iifl-logo-icon 1

Kwality Pharmaceuticals Ltd Share Price

497.4
(0.68%)
Jul 16, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open494.1
  • Day's High498.95
  • 52 Wk High590
  • Prev. Close494.05
  • Day's Low494
  • 52 Wk Low308.7
  • Turnover (lac)17.21
  • P/E17.62
  • Face Value10
  • Book Value216.98
  • EPS28.23
  • Mkt. Cap (Cr.)516.11
  • Div. Yield0
No Records Found

Kwality Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

494.1

Prev. Close

494.05

Turnover(Lac.)

17.21

Day's High

498.95

Day's Low

494

52 Week's High

590

52 Week's Low

308.7

Book Value

216.98

Face Value

10

Mkt Cap (₹ Cr.)

516.11

P/E

17.62

EPS

28.23

Divi. Yield

0

Kwality Pharmaceuticals Ltd Corporate Action

8 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

7 Sep 2023

12:00 AM

BookCloser

arrow

8 Sep 2023

12:00 AM

AGM

Announcement Date: 08 Sep, 2023

arrow

Kwality Pharmaceuticals Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Kwality Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

17 Jul, 2024|01:58 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 54.82%

Foreign: 0.00%

Indian: 54.82%

Non-Promoter- 45.17%

Institutions: 0.00%

Non-Institutions: 45.17%

Custodian: 0.00%

Share Price

Kwality Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

10.38

10.38

10.38

10.38

Preference Capital

0

0

0

0

Reserves

191.65

172.18

52.13

36.72

Net Worth

202.03

182.56

62.51

47.1

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Revenue

261.5

138.68

165.15

136.82

yoy growth (%)

88.56

-16.02

20.7

43.54

Raw materials

-165.59

-87.07

-119.34

-101.28

As % of sales

63.32

62.78

72.26

74.02

Employee costs

-15.67

-11.68

-8.42

-5.53

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

21.79

11.14

10.89

7.55

Depreciation

-6.43

-4.39

-3.05

-2.85

Tax paid

-6.38

-2.7

-3.34

-2.87

Working capital

3.88

11.55

1.1

6.11

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2019Mar-2018

Growth matrix (%)

Revenue growth

88.56

-16.02

20.7

43.54

Op profit growth

107.32

-7.37

32.62

34.55

EBIT growth

78.98

4.05

34.65

26.66

Net profit growth

82.82

11.71

61.4

35.96

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

307.17

251.03

456.19

262.01

139.3

Excise Duty

0

0

0

0

0

Net Sales

307.17

251.03

456.19

262.01

139.3

Other Operating Income

0

0

0

0

0

Other Income

1.83

2.94

3.51

1.59

3.66

Kwality Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,579.25

124.153,78,914.98867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,511.35

32.861,22,044.231,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,564.95

76.931,21,185.085310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,184.85

34.691,19,223.631,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,643.15

25.871,10,827.471,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Kwality Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Managing Director

Ramesh Arora

Whole-time Director

Ajay Arora

Independent Director

Ravi Shanker Singh

Whole-time Director

Geeta Arora

Whole-time Director

Anju Arora

Whole Time Director & CFO

Aditya Arora

Independent Director

Pankaj Takkar

Independent Director

Kiran Kumar Verma

Company Sec. & Compli. Officer

Gurpreet Kaur

Independent Director

Kartik Kapur

Director

Sachin Seth

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics. With little background of finished pharmaceuticals and high held spirits and will, he started this business. He received his first drug license in 1981 approved for liquid oral manufacturing. Presently, the Company has 48 different sections available at their production centres.Kwality Pharmaceuticals Ltd. are manufacturer of finished pharmaceutical formulations in a Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectables. The Company has the most modern & sophisticated Plant, Equipment, technique, and workforce. Certified as ISO: 9001:2015 and ISO 14001:2015, it is working with new SCHEDULE M and WHO norms and certified with GMP. The Company is keeping all records of inputs used in manufacturing. The inputs are tested as per standard laid down by company SOP. The in-process testing records are also maintained as per SOP. Similarly, finished goods are also tested as per SOP and are then allowed for sale. Apart from these, the Company is making medicines in various dosage forms like Liquid Orals, Powder for Oral Suspension, Tablets, Capsules, Dry Syrup, Syrup, Sterile Powder for Injections, small volume injectables, Ointments, External Preparations, ORS and many more in various categories like Beta Lactam & non-Bet
Read More

Company FAQs

What is the Kwality Pharmaceuticals Ltd share price today?

Down Arrow

The Kwality Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹497.4 today.

What is the Market Cap of Kwality Pharmaceuticals Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Kwality Pharmaceuticals Ltd is ₹516.11 Cr. as of 16 Jul ‘24

What is the PE and PB ratio of Kwality Pharmaceuticals Ltd?

Down Arrow

The PE and PB ratios of Kwality Pharmaceuticals Ltd is 17.62 and 2.29 as of 16 Jul ‘24

What is the 52 Week High and Low of Kwality Pharmaceuticals Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Kwality Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Kwality Pharmaceuticals Ltd is ₹308.7 and ₹590 as of 16 Jul ‘24

What is the CAGR of Kwality Pharmaceuticals Ltd?

Down Arrow

Kwality Pharmaceuticals Ltd's CAGR for 5 Years at 61.70%, 3 Years at 41.25%, 1 Year at 46.40%, 6 Month at 5.36%, 3 Month at 9.96% and 1 Month at -9.26%.

What is the shareholding pattern of Kwality Pharmaceuticals Ltd?

Down Arrow

The shareholding pattern of Kwality Pharmaceuticals Ltd is as follows:
Promoters - 54.83 %
Institutions - 0.00 %
Public - 45.17 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.